As shown in revised_Figure 8B, we found UVM cases with high levels of mRNA expression of SPTBN1 in tumor samples (high SPTBN1-expression UVM group, 29 subjects) had obvious shorter OS times than that with low expression levels of SPTBN1 (low SPTBN1-expression UVM group, 28 subjects) (Log Rank = 4.357, p = 0.036) (revised_Supplementary File 4), which was consistent with our previous TCGA findings in UVM patients. The gene discussed is SPTBN1; the disease is neoplasm.